Trial Profile
Safety of inecalcitol in combination with docetaxel in patients with castration-resistant prostate cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Inecalcitol (Primary) ; Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions
- 20 Nov 2015 New trial record